Tripartite Interplay of Epithelial, Immune, and Microbiota Dysregulation in Crohn's Disease: Mechanisms and Translational Strategies

Microbiome‐Immune Crosstalk in Inflammatory Skin Diseases: Mechanisms and Therapeutic Potential of Probiotics

The gut–skin axis links intestinal microbial activity with inflammatory skin disease, yet findings across atopic dermatitis, acne vulgaris, and psoriasis remain inconsistent. This review examines how disease biology and host context shape microbiome‐related effects and responses to probiotics.

Gut microbiota–host co-metabolism in sepsis and critical illness: source, compartment, immune state, and host defense

Editorial for Special Issue “Dietary and Animal Gut Microbiota”

The gut microbiota has long been recognized as a critical "hidden organ" that interacts dynamically with host animals, playing irreplaceable roles in regulating nutrient metabolism, shaping immune function, and maintaining systemic health [...].

Integrated Analysis of Gut Microbiota and Fecal Metabolites in Chinese Patients With Rheumatoid Arthritis: Associations With Disease Activity

This study aimed to delineate fecal microbiome and metabolomic signatures in RA and identify biomarkers associated with disease activity and identify biomarkers associated with disease activity.

Microbiome-Driven Strategies in the Management of Inflammatory Bowel Disease

Inflammatory Bowel Disease (IBD) is a chronic, relapsing inflammatory disorder of the gastrointestinal tract that arises from complex interactions among genetic susceptibility, environmental factors, immune dysregulation, and alterations in the gut microbiota. Increasing evidence has established gut microbial dysbi...

Innovative Technologies in Social Science

A growing body of epidemiological evidence indicates that patients with IBD carry an elevated risk of cardiovascular events, including coronary artery disease, stroke, heart failure (HF), venous thromboembolism (VTE)